Eastland chief executive Dermot Patterson told BTN the 30-patient open label study met its endpoints, though the company was still waiting for its final data pack.
That is great news that it met its end points. (see here: http://clinicaltrials.gov/show/NCT01047436 )
But given we had a team of scientists working on the results for a couple of months - why doesnt the company have the final data pack?
phase iii to phase iia , page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
